Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 13 of 13 for “"Relaxin-2"”.

  1. The neuroprotective effects of relaxin-2 and relaxin-3

    … of the neuroprotective effects of the peptides relaxin-2 and relaxin-3. Previous studies have shown that intracerebral relaxin-2 reduces brain lesion size in an in vivo model of stroke, thereby providing evidence of a neuroprotective action of relaxin-2. This thesis set out to extend this work …

    guelph Repository record for The neuroprotective effects of relaxin-2 and relaxin-3 (opens in a new tab)

  2. Pharmakologische Postkonditionierung mit Neuregulin-1ß und Relaxin-2 im 24-Stunden- in vivo -Langzeitversuch

    … Versuchen wurden Neuregulin-1β (NRG) und Relaxin-2 (RLX) als potenzielle Kandidaten mit vielversprechenden Ergebnissen identifiziert. Fragestellung: Mit dieser Arbeit soll gezeigt werden, dass Neuregulin-1β und Relaxin-2 entweder einzeln oder in der Kombination im in vivo Rattenmodell des …

    qucosa-diss

  3. Targeted delivery of relaxin-2 as a novel protein therapeutic for the treatment of fibrotic diseases

    … using the endogenous peptide hormone, human relaxin-2 (RLX-2), combined with mechanisms to enhance its therapeutic potential and antifibrotic efficacy. RLX-2 is a natural antifibrotic and antifibrogenic with the ability to both inhibit pathways responsible for fibrosis development and …

    bu Repository record for Targeted delivery of relaxin-2 as a novel protein therapeutic for the treatment of fibrotic diseases (opens in a new tab)

  4. The antifibrotic properties of relaxin-2 and its novel use for the treatment of adhesive capsulitis

    … to the naturally-occurring pregnancy hormone relaxin-2. This insulin-like peptide hormone readies the pubic symphysis and systemic vasculature for child birth by shifting the ECM homeostasis to a less fibrotic state, augmenting cardiac output and facilitating parturition without increasing …

    bu Repository record for The antifibrotic properties of relaxin-2 and its novel use for the treatment of adhesive capsulitis (opens in a new tab)

  5. Ανάπτυξη λιποσωμικών μορφών ρελαξίνης-2 και παραγώγων αυτής, για παράταση της διάρκειας δράσης τους

    … circulatory system. In the present dissertation, Relaxin-2 (RLX2), a multifunctional hormone of the insulin-like peptide family, was investigated. This peptide exerts beneficial effects on multiple systems, including the brain, kidneys, reproductive system, and the cardiorespiratory system. The …

    greece Repository record for Ανάπτυξη λιποσωμικών μορφών ρελαξίνης-2 και παραγώγων αυτής, για παράταση της διάρκειας δράσης τους (opens in a new tab)

  6. Myostatin – seine Koronarbilanz und zirkulierende Serumspiegel in Abhängigkeit von kardialem Status und Therapie

    … Langzeit-Monitoring mit vasodilatatorischem Relaxin-2 behandelt, 24h nachbeobachtet und je einer Gruppe mit oder ohne klinisch-hämodynamischer Verbesserung zugeordnet. Über den gesamten Verlauf werden seriell venös-systemisch NT-proBNP und Myostatin bestimmt. Ergebnisse: Nach Bestimmung der …

    fu-berlin Repository record for Myostatin – seine Koronarbilanz und zirkulierende Serumspiegel in Abhängigkeit von kardialem Status und Therapie (opens in a new tab)

  7. Coronary vascular dysfunction: diagnostic evaluation and therapeutic modification

    … 5. To evaluate the effects of recombinant relaxin-2 (serelaxin) on coronary microvascular and systemic macrovascular function in patients with stable angina. Methods: I performed two studies of diagnostic testing of vascular function, and two mechanistic trials of novel therapeutic …

    glasgow Repository record for Coronary vascular dysfunction: diagnostic evaluation and therapeutic modification (opens in a new tab)

  8. Deciphering The Effects Of Serelaxin On The Cardiorenal Axis In Acute Heart Failure- A Canine Model

    … function, and progressive end-organ failure. Serelaxin (SLX), a recombinant form of the human hormone relaxin 2, is a vasodilator and an ideal pharmacological agent to treat acute HF. Though SLX was associated with positive preliminary outcome data for acute HF it however failed to provide …

    wayne-thes Repository record for Deciphering The Effects Of Serelaxin On The Cardiorenal Axis In Acute Heart Failure- A Canine Model (opens in a new tab)

  9. Novel insights into the vasodilatory effects of relaxins and supraspinal sympathetic control of murine peripheral arteries

    … novel insights into the vasodilatory effects of relaxins and supraspinal sympathetic control of peripheral arteries interconnected with increased arterial stiffness. In particular, (1) the vasodilatory effects of relaxins in peripheral arteries, (2) the contribution of renin-angiotensin system …

    fu-berlin Repository record for Novel insights into the vasodilatory effects of relaxins and supraspinal sympathetic control of murine peripheral arteries (opens in a new tab)

  10. Therapeutic Targeting of Relaxin Signaling in Ischemic Heart Disease

    … improving cardiac health after MI. To this, relaxin-2 – the peptide hormone that regulates maternal hemodynamic function during pregnancy – has been effective in preclinical studies in countering several of the inflammatory, pro-fibrotic and pro-arrhythmogenic changes in the infarcted heart. …

    vcu Repository record for Therapeutic Targeting of Relaxin Signaling in Ischemic Heart Disease (opens in a new tab)

  11. Biotherapeutic potentiation for the treatment of musculoskeletal disease

    … An endogenously occurring peptide hormone, human relaxin-2 (RLX), shows promise as an anti-fibrotic, but multiple clinical programs have failed due to pharmacokinetic barriers and issues of receptor dysregulation. To address the pharmacokinetic limitations of RLX, we develop a tailored drug …

    bu Repository record for Biotherapeutic potentiation for the treatment of musculoskeletal disease (opens in a new tab)

  12. Pro-Enkephalin and Pro-Relaxin2 as Biomarkers for (Dys-)Function of Mammalian Kidney

    … in patients with restricted renal function. Relaxin 2 (RLX2) is known to alter renal hemodynamics in pregnant women and recently the recombinant RLX2 was suggested as therapeutic intervention in several diseases involving renal dysfunction. Methods: 3 new assay systems were developed and …

    fu-berlin Repository record for Pro-Enkephalin and Pro-Relaxin2 as Biomarkers for (Dys-)Function of Mammalian Kidney (opens in a new tab)

  13. Ο ρόλος της ρελαξίνης στις αγγειακές παθήσεις

    Introduction: Since its discovery in 1926, relaxin has been regarded as a peptide hormone that plays a role in the enlargement of pubic symphysis during the perinatal period. Since then, it has been found to exhibit a variety of biological functions in various organs and systems, especially the …

    greece Repository record for Ο ρόλος της ρελαξίνης στις αγγειακές παθήσεις (opens in a new tab)